NCT06665672 (Sleep-Vibe) is a NA clinical trial of Wrist worn vibro-acoustic device in Sleep Duration, sponsored by Daniel Patterson, PhD, NRP.

Who is sponsoring NCT06665672?

NCT06665672 is sponsored by Daniel Patterson, PhD, NRP.

What drugs are being tested in NCT06665672?

Interventions in NCT06665672: Wrist worn vibro-acoustic device.

What condition does NCT06665672 study?

NCT06665672 studies Sleep Duration, Psychomotor Performance.

Is NCT06665672 still recruiting?

NCT06665672 is currently completed. Last updated 3 April 2026.

Last reviewed 2026-04-03 · How we verify

NCT06665672: Sleep-Vibe

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of a Wrist-worn Device That Produces a Small Vibration on Sleep and Performance That Can Occur During and After Night Shift Work

Completed NA Last updated 3 April 2026

What this trial tests

NA trial testing Wrist worn vibro-acoustic device in Sleep Duration in 21 participants. Completed in 12 December 2025.

Timeline

26 November 2024

Primary endpoint
11 December 2025

12 December 2025

Quick facts

Lead sponsor	Daniel Patterson, PhD, NRP
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	21
Start date	26 November 2024
Primary completion	11 December 2025
Estimated completion	12 December 2025
Sites	1 location across United States

Drugs / interventions tested

Wrist worn vibro-acoustic device

Conditions studied

Sleep Duration — all drugs for Sleep Duration →
Psychomotor Performance — all drugs for Psychomotor Performance →

Sponsor

Daniel Patterson, PhD, NRP

Who can join

18 and older, any sex, with Sleep Duration or Psychomotor Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work. Aim 1: To determine the effect of the ApolloNeuro device on sleep duration, sleep architecture, blood pressure, heart rate variability, and subjective ratings of sleep quality during and after simulated night shift work. Aim 2: To determine the effect of the ApolloNeuro device on post-sleep psychomotor performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Duration

Currently open trials in the same condition.

NCT06341179 — Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep) · NA · recruiting
NCT05475262 — Sleepless at Scripps: An Inpatient White Noise Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06665672 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Daniel Patterson, PhD, NRP
Last refreshed: 3 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06665672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing